GFC Life Science Co., Ltd. (388610) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GFC Life Science Co., Ltd. (388610:KRX), powered by AI.

Current Price
₩6,560
P/E Ratio
62.9
Market Cap
34.9B
Sector
Unknown
What is the GFC Life Science Co., Ltd. stock price forecast?

GFC Life Science Co., Ltd. is currently trading at ₩6,560. View real-time AI analysis on Alpha Lenz.

What is GFC Life Science Co., Ltd. insider trading activity?

View the latest insider trading data for GFC Life Science Co., Ltd. on Alpha Lenz.

What is GFC Life Science Co., Ltd.'s P/E ratio?

GFC Life Science Co., Ltd.'s P/E ratio is 62.9.

GFC Life Science Co., Ltd.

KRX · 388610
₩6,560-250(-3.67%)Market closedKRX regular session 09:00–15:30 KST
Ask about GFC Life Science Co., Ltd.'s future dividend policy...
Alpha Chat Insight

GFC Life Science Co., Ltd. trades at a P/E of 62.9 (premium valuation) with modest ROE of 3.2%.

Ask for details

Company Overview

GFC Life Science Co., Ltd. is a company that operates primarily in the biotechnology and pharmaceutical industries. The firm is engaged in the development, manufacture, and sale of various life science products and technologies. Its primary function is to enhance the quality and effectiveness of healthcare and medical research through innovative solutions. The company is focused on a broad range of applications, including biotechnological advancements, pharmaceutical manufacturing, and healthcare technology. GFC Life Science Co., Ltd. plays a significant role in these industries by providing breakthrough products that support drug discovery, medical diagnostics, and therapeutic developments. It is actively involved in both the domestic and international markets, catering to the growing demand for advanced medical technologies and pharmaceuticals. With an emphasis on research and development, GFC Life Science Co. continues to contribute to the advancement of medical sciences, impacting various sectors such as healthcare, agriculture, and environmental protection. The company's contributions are critical in a market increasingly driven by technological advancements and the need for sustainable healthcare solutions, making it a pivotal player in the life sciences sector.

CEO강희철,표형배
SectorUnknown
IndustryUnknown
0

Company Statistics

FY 2025

Profile

₩34,934,512,480Market Cap
₩17,714,780,990Revenue
5.33MShares Out
0Employees

Margins

48.04%Gross
12.57%EBITDA
2.18%Operating
0.56%Pre-Tax
3.14%Net

Valuation

62.90P/E
1.47P/B
1.97EV/Sales
15.71EV/EBITDA
-5.51P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

2.06%ROA
3.20%ROE
1.47%ROIC

Financial Health

₩7,470,180,310Cash & Cash Equivalents
₩2,564,433,040Net Debt
42.16%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

GFC Life Science Co., Ltd. (ticker: 388610) is a company listed on KRX in the Unknown sector (Unknown). Market cap is $34.9B.

The current price is ₩6,560 with a P/E ratio of 62.9x and P/B of 1.47x.

ROE is 3.20% and operating margin is 2.18%. Annual revenue is $17.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
GFC Life Science Co., Ltd. (388610) Stock Forecast 2026 ₩6,560 — Price, Financials & Analyst Targets | Alpha Lenz